Epilepsy Trial, Recruiting (NCT04076449)

Epilepsy Trial, Recruiting NCT04076449 Sponsor: yuanli Zhao Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT04076449 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People between 18 and 70 years of age
People who have been diagnosed with a single cerebral cavernous malformation (an abnormal cluster of blood vessels in the brain)
People whose affected area of the brain has not previously been treated

Who may not be able to join:

People who have other brain lesions or tumours in addition to the cavernous malformation
People who have had surgery inside the skull at any point in the past
People who have previously had radiation treatment to the brain
People for whom MRI scans are not medically suitable, or who are unwilling or unable to have MRI scans as part of the research
Women who are pregnant or breastfeeding
People who are unlikely or unable to return for follow-up visits during the trial
People living with dementia or another progressive neurological condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Li Ma, MD, PhD, Beijing Tiantan Hospital

Phone: 86-010-59978317

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04076449

Sponsor: yuanli Zhao

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 86-010-59978317

More information: https://clinicaltrials.gov/study/NCT04076449

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People between 18 and 70 years of age
People who have been diagnosed with a single cerebral cavernous malformation (an abnormal cluster of blood vessels in the brain)
People whose affected area of the brain has not previously been treated

Who may not be able to join:

People who have other brain lesions or tumours in addition to the cavernous malformation
People who have had surgery inside the skull at any point in the past
People who have previously had radiation treatment to the brain
People for whom MRI scans are not medically suitable, or who are unwilling or unable to have MRI scans as part of the research
Women who are pregnant or breastfeeding
People who are unlikely or unable to return for follow-up visits during the trial
People living with dementia or another progressive neurological condition

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

yuanli Zhao

Registry

ClinicalTrials.gov

Start date

3 September 2019

Est. completion

31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Perilesional mean QSM in CCM with conservative treatment; Perilesional mean QSM after surgical resection of CCM lesion; Ratio of seizure freedom during follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov